Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose In young patients (aged 18–60 years) with patent foramen ovale (PFO)- associated stroke, percutaneous closure has been found to be useful for preventing recurrent ischemic stroke or transient ischemic attack (TIA). However, it remains unknown whether PFO closure is also beneficial in older patients. Methods Patients aged ≥60 years who had a cryptogenic stroke and PFO from ten hospitals in South Korea were included. The effect of PFO closure plus medical therapy over medical therapy alone was assessed by a propensity-score matching method in the overall cohort and in those with a high-risk PFO, characterized by the presence of an atrial septal aneurysm or a large shunt. Results Out of the 437 patients (mean age, 68.1), 303 (69%) had a high-risk PFO and 161 (37%) patients underwent PFO closure. Over a median follow-up of 3.9 years, recurrent ischemic stroke or TIA developed in 64 (14.6%) patients. In the propensity score-matched cohort of the overall patients (130 pairs), PFO closure was associated with a significantly lower risk of a composite of ischemic stroke or TIA (hazard ratio [HR]: 0.45; 95% confidence interval [CI]: 0.24–0.84; P=0.012), but not for ischemic stroke. In a subgroup analysis of confined to the high-risk PFO patients (116 pairs), PFO closure was associated with significantly lower risks of both the composite of ischemic stroke or TIA (HR: 0.40; 95% CI: 0.21–0.77; P=0.006) and ischemic stroke (HR: 0.47; 95% CI: 0.23–0.95; P=0.035). Conclusion Elderly patients with cryptogenic stroke and PFO have a high recurrence rate of ischemic stroke or TIA, which may be significantly reduced by device closure.
Abstract
Background and Purpose In young patients (aged 18–60 years) with patent foramen ovale (PFO)- associated stroke, percutaneous closure has been found to be useful for preventing recurrent ischemic stroke or transient ischemic attack (TIA). However, it remains unknown whether PFO closure is also beneficial in older patients. Methods Patients aged ≥60 years who had a cryptogenic stroke and PFO from ten hospitals in South Korea were included. The effect of PFO closure plus medical therapy over medical therapy alone was assessed by a propensity-score matching method in the overall cohort and in those with a high-risk PFO, characterized by the presence of an atrial septal aneurysm or a large shunt. Results Out of the 437 patients (mean age, 68.1), 303 (69%) had a high-risk PFO and 161 (37%) patients underwent PFO closure. Over a median follow-up of 3.9 years, recurrent ischemic stroke or TIA developed in 64 (14.6%) patients. In the propensity score-matched cohort of the overall patients (130 pairs), PFO closure was associated with a significantly lower risk of a composite of ischemic stroke or TIA (hazard ratio [HR]: 0.45; 95% confidence interval [CI]: 0.24–0.84; P=0.012), but not for ischemic stroke. In a subgroup analysis of confined to the high-risk PFO patients (116 pairs), PFO closure was associated with significantly lower risks of both the composite of ischemic stroke or TIA (HR: 0.40; 95% CI: 0.21–0.77; P=0.006) and ischemic stroke (HR: 0.47; 95% CI: 0.23–0.95; P=0.035). Conclusion Elderly patients with cryptogenic stroke and PFO have a high recurrence rate of ischemic stroke or TIA, which may be significantly reduced by device closure.
참고문헌 (31)
- Lechat P, "Prevalence of patent foramen ovale in patients with stroke", N Engl J Med, 318, pp.1148~1152 (1988)
- Webster MW, "Patent foramen ovale in young stroke patients", Lancet, 2, pp.11~12 (1988)
- Carroll JD, "Closure of patent foramen ovale versus medical therapy after cryptogenic stroke", N Engl J Med, 368, pp.1092~1100 (2013)
- Furlan AJ, "Closure or medical therapy for cryptogenic stroke with patent foramen ovale", N Engl J Med, 366, pp.991~999 (2012)
- Mas JL, "Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke", N Engl J Med, 377, pp.1011~1021 (2017)
- Meier B, "Percutaneous closure of patent foramen ovale in cryptogenic embolism", N Engl J Med, 368, pp.1083~1091 (2013)
- Saver JL, "Long-term outcomes of patent foramen ovale closure or medical therapy after stroke", N Engl J Med, 377, pp.1022~1032 (2017)
- Søndergaard L, "Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke", N Engl J Med, 377, pp.1033~1042 (2017)
- Lee PH, "Cryptogenic stroke and high-risk patent foramen ovale : the DEFENSEPFO trial", J Am Coll Cardiol, 71, pp.2335~2342 (2018)
- Kleindorfer DO, "2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack : a guideline from the American Heart Association", American Stroke Association, 2021, pp.52, e364~e467
- Messé SR, "Practice advisory update summary : patent foramen ovale and secondary stroke prevention : report of the guideline subcommittee of the American Academy of Neurology", Neurology, 94, pp.876~885 (2020)
- Pristipino C, "European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism", Eur Heart J, 40, pp.3182~3195 (2019)
- Kent DM, "Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke", JAMA, 326, pp.2277~2286 (2021)
- Overell JR, "Interatrial septal abnormalities and stroke : a meta-analysis of case-control studies", Neurology, 55, pp.1172~1179 (2000)
- Kim JS, "Establishment of the heart and brain team for patent foramen ovale closure in stroke patients : an expert opinion", J Stroke, 24, pp.345~351 (2022)
- Mehran R, "Standardized bleeding definitions for cardiovascular clinical trials : a consensus report from the bleeding academic research consortium", Circulation, 123, pp.2736~2747 (2011)
- Hagen PT, "Incidence and size of patent foramen ovale during the first 10 decades of life : an autopsy study of 965 normal hearts", Mayo Clin Proc, 59, pp.17~20 (1984)
- Handke M, "Patent foramen ovale and cryptogenic stroke in older patients", N Engl J Med, 357, pp.2262~2268 (2007)
- Mazzucco S, "Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages : a population-based study, systematic review, and meta-analysis", Lancet Neurol, 17, pp.609~617 (2018)
- Brown RD, "Stroke incidence, prevalence, and survival : secular trends in Rochester, Minnesota, through 1989", Stroke, 27, pp.373~380 (1996)
- Marinigh R, "Age as a risk factor for stroke in atrial fibrillation patients : implications for thromboprophylaxis", J Am Coll Cardiol, 56, pp.827~837 (2010)
- Wolf PA, "Secular trends in stroke incidence and mortality. The Framingham study", Stroke, 23, pp.1551~1555 (1992)
- Ntaios G, "Age-and sex-specific analysis of patients with embolic stroke of undetermined source", Neurology, 89, pp.532~539 (2017)
- Mazzucco S, "Prognosis of cryptogenic stroke with patent foramen ovale at older ages and implications for trials : a population-based study and systematic review", JAMA Neurol, 77, pp.1279~1287 (2020)
- Diener HC, "Dabigatran for prevention of stroke after embolic stroke of undetermined source", N Engl J Med, 380, pp.1906~1917 (2019)
- Kasner SE, "Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source : a prespecified subgroup analysis from the NAVIGATE ESUS trial", Lancet Neurol, 17, pp.1053~1060 (2018)
- Elgendy AY, "Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke", JAMA Neurol, 77, pp.878~886 (2020)
- Alperi A, "Transcatheter closure of patent foramen ovale in older patients with cryptogenic thromboembolic events", Circ Cardiovasc Interv, 15, pp.e011652~ (2022)
- Kwon H, "Patent foramen ovale closure in old stroke patients : a subgroup analysis of the DEFENSE-PFO trial", J Stroke, 23, pp.289~292 (2021)
- Merkler AE, "Safety outcomes after percutaneous transcatheter closure of patent foramen ovale", Stroke, 48, pp.3073~3077 (2017)
- Tsivgoulis G, "Prolonged cardiac monitoring and stroke recurrence : a meta-analysis", Neurology, 98, pp.e1942~e1952 (2022)